Properties
Description
Tazemetostat hydrobromide inhibits the enzymes that add methyl groups to histone proteins, altering chromatin structure and gene expression.
Molecular Formula
C34H45BrN4O4
Identity
Confirmed by NMR/HPLC/MS.
Applications
Tazemetostat hydrobromide can be used to inhibit EZH2 in cancer therapies, particularly lymphomas.